Eprogen
Growing Demand for Integrated Workflows Drives Formation of 13-Firm Proteomics Innovation Network
Premium
According to Matthew Kuruc, COO of PIN member ProFact Proteomics, the network aims to help smaller firms offer complete solutions similar to those increasingly provided by large instrument vendors and to popularize non-mass spec-based proteomics workflows.
Although it's too early to announce biopharma partners, the 13 companies involved in the network are hoping that their collective skills and specialties will attract companies interested in developing drugs targeted to specific proteomic markers in patients.
The group aims to provide solutions for all stages of proteomics research and address "critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring."
Over the past week, OGT acquired protein-array maker Sense Proteomic, Aushon bought Thermo's SearchLight protein-array business, and Gentel and Eprogen allied to help drug makers identify new autoantibody biomarkers.
Industry Briefs : Mar 12, 2009
Premium
Gentel, Eprogen, Novozymes, Proteome Sciences, Pepsca, Advanced Proteome Therapeutics, AnaSpec
Mar 11, 2009